Perspectives on the Changing Landscape of Measuring Cardiovascular Risk Related to LDL

低密度脂蛋白胆固醇 动脉粥样硬化性心血管疾病 医学 风险评估 内科学 胆固醇 国家胆固醇教育计划 内分泌学 疾病 计算机科学 计算机安全 代谢综合征 肥胖
作者
Joe M El-Khoury,Alan T. Remaley,Børge G. Nordestgaard,Harvey W. Kaufman,Samia Mora,Jing Cao,Jeffrey W. Meeusen
出处
期刊:Clinical Chemistry [Oxford University Press]
卷期号:65 (12): 1487-1492 被引量:3
标识
DOI:10.1373/clinchem.2019.307306
摘要

The clinical laboratory plays a critical role in the assessment of atherosclerotic cardiovascular disease (ASCVD)9 risk. Since the 1970s, this laboratory assessment has been primarily through tests in the lipid panel, which included cholesterol, triglycerides (TG), and HDL cholesterol (HDL-C) based on fasting serum or plasma specimens. Until the advent of direct LDL cholesterol (LDL-C) tests approximately 20 years ago, LDL-C was almost exclusively estimated by the Friedewald equation (valid when TG <400 mg/dL or <4.5 mmol/L), and to date the vast majority of LDL-C is still calculated. This testing paradigm has undergone substantial changes over the past decade, with the emergence of new research and guidelines recommending alternate approaches for the laboratory assessment of ASCVD risk. As early as 2009, various clinical laboratory associations started recommending the use of a nonfasting specimen for routine lipid panels as a result of several studies supporting its use in cardiovascular risk assessment. In 2013, Martin and coworkers reported a new equation for estimating LDL-C that was more accurate than the Friedewald equation when compared to ultracentrifugation method (also known as β quantification). This new equation was reported to overcome the poor performance of the Friedewald equation at TG >150 mg/dL (>1.7 mmol/L) and at low concentrations of LDL-C (<70 mg/dL or <1.8 mmol/L), which may now be more common and clinically relevant owing to the use of more effective lipid-lowering therapy. Not all studies, however, have shown a significant difference between the old and new LDL-C equations when compared to preparative ultracentrifugation, the gold standard method for measuring LDL-C. Nevertheless, many clinical laboratories and at least one major provider of diagnostic testing services in the US switched to the new equation in 2017. In 2018, the American College of Cardiology and the American Heart Association (ACC/AHA) published new guidelines on the …

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
所所应助梦溪采纳,获得10
刚刚
刚刚
宋松桦完成签到,获得积分20
刚刚
Kidmuse发布了新的文献求助10
刚刚
Xerxez完成签到,获得积分10
1秒前
燕南大厨子完成签到,获得积分20
1秒前
Re完成签到,获得积分10
2秒前
2秒前
2秒前
飘逸访蕊发布了新的文献求助10
2秒前
墨菲完成签到,获得积分10
2秒前
张赫兹发布了新的文献求助10
2秒前
77发布了新的文献求助10
3秒前
3秒前
风清扬应助lian采纳,获得30
3秒前
共享精神应助冲冲冲采纳,获得30
3秒前
4秒前
大模型应助欢呼的开山采纳,获得10
4秒前
候鸟完成签到,获得积分20
4秒前
5秒前
中央戏精学院完成签到,获得积分10
5秒前
量子星尘发布了新的文献求助10
5秒前
Xerxez发布了新的文献求助10
5秒前
5秒前
zzz发布了新的文献求助10
6秒前
无私的笑蓝完成签到,获得积分10
6秒前
陈陈发布了新的文献求助10
6秒前
大力帽子应助Dr.Invincible采纳,获得10
6秒前
Ava应助wzy采纳,获得10
6秒前
6秒前
科研通AI6应助QH采纳,获得10
7秒前
墨菲发布了新的文献求助10
7秒前
7秒前
仇文琪完成签到,获得积分10
8秒前
悦耳念梦完成签到,获得积分10
8秒前
李文强发布了新的文献求助10
9秒前
9秒前
成就的南霜完成签到,获得积分10
9秒前
licc发布了新的文献求助10
9秒前
winnie发布了新的文献求助10
9秒前
高分求助中
2025-2031全球及中国金刚石触媒粉行业研究及十五五规划分析报告 12000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1000
Russian Foreign Policy: Change and Continuity 800
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 800
Advanced Memory Technology: Functional Materials and Devices 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5692686
求助须知:如何正确求助?哪些是违规求助? 5089409
关于积分的说明 15209142
捐赠科研通 4849841
什么是DOI,文献DOI怎么找? 2601323
邀请新用户注册赠送积分活动 1553128
关于科研通互助平台的介绍 1511300